How Leqembi improves Alzheimer’s disease?

Leqembi is a medication that treats Alzheimer's disease and improves the quality of life for those affected. A key factor in the development of Alzheimer's disease is the buildup of amyloid beta (Aβ) proteins in the brain, which forms plaques that damage nerve cells and lead to symptoms like memory loss and confusion.

Leqembi is a special type of protein called a monoclonal antibody that binds to Aβ plaques and removes them from the brain. By clearing the plaques, Leqembi can slow down the progression of Alzheimer's disease and improve symptoms.

Leqembi is administered as an IV infusion every 2 weeks, but it is not yet known how long the medication needs to be taken to maintain its benefits. Additionally, although it has been shown to improve symptoms of Alzheimer's disease, it is not known if it is safe and effective for people with other types of dementia.

It's important to note that Leqembi is not a cure for Alzheimer's disease and may have side effects such as headaches, infusion-related reactions, and amyloid-related imaging abnormalities (ARIA). ARIA can be mild or severe, and can include brain swelling, bleeding, and inflammation. However, if you're thinking of taking Leqembi, speaking with your doctor is a good first step.